\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\\	large\\ bilateral\\ pretibial\\ deep\\ ulcerations\\ and\\ scattered\\ erythematous\\ indurated\\ nodules\\ and\\ plaques\\ on\\ the\\ anterior\\ thighs\\.\ \(0\)\
\-\ laboratory\\:\\ cbc\\:\\ wbc\\ 8\\.7\\,\\ hgb\\ 14\\.3\\,\\ hct\\ 43\\.1\\,\\ platelets\\ 348\\,\\ differential\\ 66\\%\\ neutrophils\\,\\ 21\\%\\ lymphocytes\\,\\ 10\\%\\ monocytes\\.\\ electrolytes\\:\\ wnl\\.\\ albumin\\ 4\\.2\\,\\ alk\\ phos\\ 104\\,\\ ast\\ 24\\,\\ ldh\\ 230\\,\\ t\\.bili\\ 5\\,\\ alt\\ 33\ \(0\)\
\-\ the\\ patient\\ underwent\\ colonoscopy\\ which\\ revealed\\ scattered\\ mucosal\\ ulcerations\\ of\\ the\\ descending\\ and\\ ascending\\ colon\\,\\ and\\ rectal\\ disease\\ with\\ ulcerations\\ and\\ pseudopolyps\\.\\ he\\ was\\ treated\\ with\\ prednisone\\ 80mg\\ qd\\ and\\ asachol\\ for\\ his\\ crohn\\ disease\\.\\ with\\ local\\ wound\\ care\\,\\ his\\ leg\\ ulcerations\\ granulated\\ and\\ healed\\ over\\ 3\\ months\\.\ \(0\)\
\-\ large\\ bilateral\\ pretibial\\ deep\\ ulcerations\\ and\\ scattered\\ erythematous\\ indurated\\ nodules\\ and\\ plaques\ \(2\)\
\-\ cutaneous\\ chron\\ disease\ \(0\)\
\-\ the\\ 33\\ y\\.o\\.\\ man\\ presented\\ initially\\ with\\ bilateral\\ lower\\ extremity\\ pretibial\\ papules\\.\\ they\\	became\\ dusky\\,\\ painful\\ and\\ progressively\\ enlarged\\ and\\ ulcerated\\ over\\ a\\ 3\\ month\\ period\\.\\ he\\ was\\ treated\\ with\\ a\\ two\\ week\\ course\\ of\\ steroids\\,\\ keflex\\,\\ and\\ itraconazole\\ all\\ without\\ response\\.\ \(0\)\
\-\ histopathology\\:\\ \\ non\\-caseating\\ granulomas\\ with\\ lymphohistiocytic\\ cells\\ and\\ numerous\\ multinucleated\\ giant\\ cells\\.\\ confluence\\ of\\ granulomas\\.\\ foci\\ of\\ necrosis\\ with\\ numerous\\ neutrophils\\ and\\ occasional\\ granulomas\\ with\\ many\\ eosinophils\\.\\ gms\\ and\\ pas\\ stains\\ were\\ negative\\,\\ as\\ were\\ afb\\ and\\ fite\\ stains\\.\ \(0\)\
\-\ cutaneous\\ \\/\\ metastatic\\ crohn\\ disease\\ \\(1997\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ case\\#13\\)\\ submitted\\ by\\:\\ maj\\ robert\\ t\\.\\ gilson\\,\\ usaf\\,\\ mc\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ulcerations\\:\\ 0\\.1257323036867269\ \(0\)\
\-\ pretibial\\:\\ 0\\.0813562813290167\ \(0\)\
\-\ granulomas\\:\\ 0\\.06351328857673313\ \(0\)\
\-\ indurated\\:\\ 0\\.048885033005239366\ \(0\)\
\-\ scattered\\:\\ 0\\.04609154266812765\ \(0\)\
\-\ stains\\:\\ 0\\.04494043359391897\ \(0\)\
\-\ neutrophils\\:\\ 0\\.04420444764948404\ \(0\)\
\-\ erythematous\\:\\ 0\\.03834263183209606\ \(0\)\
\-\ cutaneous\\:\\ 0\\.03834263183209606\ \(0\)\
\-\ plaques\\:\\ 0\\.036853028232679136\ \(0\)\
\-\ crohn\\:\\ 0\\.03526658827735243\ \(0\)\
\-\ 33\\:\\ 0\\.034235457832375416\ \(0\)\
\-\ 348\\:\\ 0\\.03403675067168532\ \(0\)\
\-\ asachol\\:\\ 0\\.03403675067168532\ \(0\)\
\-\ gilson\\:\\ 0\\.03403675067168532\ \(0\)\
\-\ 43\\.1\\:\\ 0\\.031360506731299434\ \(0\)\
\-\ t\\.bili\\:\\ 0\\.031360506731299434\ \(0\)\
\-\ pseudopolyps\\:\\ 0\\.031360506731299434\ \(0\)\
\-\ granulated\\:\\ 0\\.031360506731299434\ \(0\)\
\-\ keflex\\:\\ 0\\.031360506731299434\ \(0\)\
\-\ fite\\:\\ 0\\.031360506731299434\ \(0\)\
\-\ non\\-caseating\\:\\ 0\\.02979500438339146\ \(0\)\
\-\ gms\\:\\ 0\\.02979500438339146\ \(0\)\
\-\ numerous\\:\\ 0\\.029590052527090054\ \(0\)\
\-\ 80mg\\:\\ 0\\.02868426279091354\ \(0\)\
\-\ lymphohistiocytic\\:\\ 0\\.02868426279091354\ \(0\)\
\-\ monocytes\\:\\ 0\\.027822704677731267\ \(0\)\
\-\ 230\\:\\ 0\\.027822704677731267\ \(0\)\
\-\ chron\\:\\ 0\\.027822704677731267\ \(0\)\
\-\ dusky\\:\\ 0\\.027822704677731267\ \(0\)\
\-\ multinucleated\\:\\ 0\\.027822704677731267\ \(0\)\
\-\ nodules\\:\\ 0\\.027355358033998082\ \(0\)\
\-\ deep\\:\\ 0\\.026709900766752784\ \(0\)\
\-\ 8\\.7\\:\\ 0\\.02652358407301616\ \(0\)\
\-\ 14\\.3\\:\\ 0\\.02652358407301616\ \(0\)\
\-\ confluence\\:\\ 0\\.02652358407301616\ \(0\)\
\-\ pas\\:\\ 0\\.02652358407301616\ \(0\)\
\-\ cells\\:\\ 0\\.02645904783127411\ \(0\)\
\-\ \\:\\:\\ 0\\.026183972571212317\ \(0\)\
\-\ itraconazole\\:\\ 0\\.026008018850527653\ \(0\)\
\-\ usaf\\:\\ 0\\.025146460737345378\ \(0\)\
\-\ ulcerated\\:\\ 0\\.024442516502619683\ \(0\)\
\-\ thighs\\:\\ 0\\.024133471299246954\ \(0\)\
\-\ bilateral\\:\\ 0\\.024021054779703982\ \(0\)\
\-\ eosinophils\\:\\ 0\\.023580958389437405\ \(0\)\
\-\ 104\\:\\ 0\\.023331774910141764\ \(0\)\
\-\ maj\\:\\ 0\\.023331774910141764\ \(0\)\
\-\ afb\\:\\ 0\\.02309770301123661\ \(0\)\
\-\ \\%\\:\\ 0\\.023088660617907424\ \(0\)\
\-\ electrolytes\\:\\ 0\\.022877014154711713\ \(0\)\
\-\ t\\.\\:\\ 0\\.022877014154711713\ \(0\)\
\-\ 4\\.2\\:\\ 0\\.02266826040463343\ \(0\)\
\-\ qd\\:\\ 0\\.021766272562233794\ \(0\)\
\-\ disease\\:\\ 0\\.021571236157771494\ \(0\)\
\-\ platelets\\:\\ 0\\.021457227358861065\ \(0\)\
\-\ papules\\:\\ 0\\.021457227358861065\ \(0\)\
\-\ lymphocytes\\:\\ 0\\.021311511806803744\ \(0\)\
\-\ albumin\\:\\ 0\\.021311511806803744\ \(0\)\
\-\ \\,\\:\\ 0\\.020904252163497096\ \(0\)\
\-\ ldh\\:\\ 0\\.020655530969755875\ \(0\)\
\-\ healed\\:\\ 0\\.0198917250109531\ \(0\)\
\-\ treated\\:\\ 0\\.01975174390798347\ \(0\)\
\-\ prednisone\\:\\ 0\\.01951474250298431\ \(0\)\
\-\ submitted\\:\\ 0\\.01951474250298431\ \(0\)\
\-\ mc\\:\\ 0\\.019339212101143546\ \(0\)\
\-\ alk\\:\\ 0\\.019254351457441712\ \(0\)\
\-\ phos\\:\\ 0\\.019254351457441712\ \(0\)\
\-\ colonoscopy\\:\\ 0\\.019254351457441712\ \(0\)\
\-\ his\\:\\ 0\\.0190184480899377\ \(0\)\
\-\ robert\\:\\ 0\\.01885595672294275\ \(0\)\
\-\ rectal\\:\\ 0\\.018707438264148172\ \(0\)\
\-\ wound\\:\\ 0\\.018494852251858488\ \(0\)\
\-\ 1997\\:\\ 0\\.018494852251858488\ \(0\)\
\-\ histopathology\\:\\ 0\\.018426514116339568\ \(0\)\
\-\ he\\:\\ 0\\.018410713065892044\ \(0\)\
\-\ hgb\\:\\ 0\\.01835936453057946\ \(0\)\
\-\ seminar\\:\\ 0\\.01835936453057946\ \(0\)\
\-\ uniformed\\:\\ 0\\.018164650810012305\ \(0\)\
\-\ hct\\:\\ 0\\.017919425305292898\ \(0\)\
\-\ ast\\:\\ 0\\.017919425305292898\ \(0\)\
\-\ alt\\:\\ 0\\.017919425305292898\ \(0\)\
\-\ became\\:\\ 0\\.017802416233882366\ \(0\)\
\-\ services\\:\\ 0\\.017802416233882366\ \(0\)\
\-\ dermatology\\:\\ 0\\.017802416233882366\ \(0\)\
\-\ 66\\:\\ 0\\.01774521513046483\ \(0\)\
\-\ progressively\\:\\ 0\\.01774521513046483\ \(0\)\
\-\ ascending\\:\\ 0\\.01768884910953374\ \(0\)\
\-\ occasional\\:\\ 0\\.01741873872881208\ \(0\)\
\-\ mucosal\\:\\ 0\\.017022390643638013\ \(0\)\
\-\ wnl\\:\\ 0\\.01692934990395052\ \(0\)\
\-\ over\\:\\ 0\\.016800328881389673\ \(0\)\
\-\ response\\:\\ 0\\.016536366528236455\ \(0\)\
\-\ \\/\\:\\ 0\\.016294975188540187\ \(0\)\
\-\ descending\\:\\ 0\\.01610473947808929\ \(0\)\
\-\ giant\\:\\ 0\\.01588817783078796\ \(0\)\
\-\ painful\\:\\ 0\\.015683120590193566\ \(0\)\
\-\ steroids\\:\\ 0\\.01552018485857049\ \(0\)\
\-\ 3\\:\\ 0\\.015451548468776369\ \(0\)\
\-\ period\\:\\ 0\\.015425624935758537\ \(0\)\
\-\ local\\:\\ 0\\.015155093805964266\ \(0\)\
\-\ were\\:\\ 0\\.014982906074825646\ \(0\)\
\-\ 21\\:\\ 0\\.01492956962775417\ \(0\)\
\-\ 13\\:\\ 0\\.01490228326781945\ \(0\)\
\-\ cbc\\:\\ 0\\.01474249478842619\ \(0\)\
\-\ large\\:\\ 0\\.014428899087498686\ \(0\)\
\-\ foci\\:\\ 0\\.01416225462221253\ \(0\)\
\-\ many\\:\\ 0\\.013560669945588504\ \(0\)\
\-\ initially\\:\\ 0\\.013428495537703398\ \(0\)\
\-\ necrosis\\:\\ 0\\.013023554878164883\ \(0\)\
\-\ leg\\:\\ 0\\.012973734782273346\ \(0\)\
\-\ colon\\:\\ 0\\.012957269922093975\ \(0\)\
\-\ \\#\\:\\ 0\\.012940874976605746\ \(0\)\
\-\ 24\\:\\ 0\\.012828019230216023\ \(0\)\
\-\ course\\:\\ 0\\.012449928353110585\ \(0\)\
\-\ laboratory\\:\\ 0\\.0121586553507879\ \(0\)\
\-\ extremity\\:\\ 0\\.0120662508480403\ \(0\)\
\-\ wbc\\:\\ 0\\.012027316025389236\ \(0\)\
\-\ care\\:\\ 0\\.011900297865130319\ \(0\)\
\-\ they\\:\\ 0\\.011887822882190372\ \(0\)\
\-\ underwent\\:\\ 0\\.01132122021420162\ \(0\)\
\-\ enlarged\\:\\ 0\\.011257224209976859\ \(0\)\
\-\ week\\:\\ 0\\.011204692734858024\ \(0\)\
\-\ 10\\:\\ 0\\.011122101267748688\ \(0\)\
\-\ and\\:\\ 0\\.011120247458360986\ \(0\)\
\-\ revealed\\:\\ 0\\.010588702277475263\ \(0\)\
\-\ differential\\:\\ 0\\.010474748375880038\ \(0\)\
\-\ month\\:\\ 0\\.009898125640156793\ \(0\)\
\-\ negative\\:\\ 0\\.009853745796814186\ \(0\)\
\-\ 5\\:\\ 0\\.009653129044185959\ \(0\)\
\-\ y\\.o\\:\\ 0\\.009522700511917762\ \(0\)\
\-\ two\\:\\ 0\\.009449155357590756\ \(0\)\
\-\ all\\:\\ 0\\.009331750924445138\ \(0\)\
\-\ months\\:\\ 0\\.0090113563501547\ \(0\)\
\-\ presented\\:\\ 0\\.008993658822480344\ \(0\)\
\-\ anterior\\:\\ 0\\.00849726958981752\ \(0\)\
\-\ metastatic\\:\\ 0\\.008305441712803438\ \(0\)\
\-\ physical\\:\\ 0\\.008094614940468101\ \(0\)\
\-\ man\\:\\ 0\\.007802825648996136\ \(0\)\
\-\ without\\:\\ 0\\.00776839060369946\ \(0\)\
\-\ was\\:\\ 0\\.007631486658020748\ \(0\)\
\-\ lower\\:\\ 0\\.007420316870130744\ \(0\)\
\-\ exam\\:\\ 0\\.007248007490152657\ \(0\)\
\-\ case\\:\\ 0\\.007218163833464366\ \(0\)\
\-\ which\\:\\ 0\\.006158859410202891\ \(0\)\
\-\ by\\:\\ 0\\.0054937100511385124\ \(0\)\
\-\ as\\:\\ 0\\.004990646740903968\ \(0\)\
\-\ with\\:\\ 0\\.0036140286050931193\ \(0\)\
\-\ patient\\:\\ 0\\.0033073047525729268\ \(0\)\
\-\ a\\:\\ 0\\.003062546732189971\ \(0\)\
\-\ for\\:\\ 0\\.0028150893769989\ \(0\)\
\-\ on\\:\\ 0\\.0027949459936889116\ \(0\)\
\-\ \\(\\:\\ 0\\.0027890414140689596\ \(0\)\
\-\ \\)\\:\\ 0\\.0027549717842212554\ \(0\)\
\-\ the\\:\\ 0\\.002135124088086885\ \(0\)\
\-\ \\.\\:\\ 0\\.0019188938430997988\ \(0\)\
\-\ of\\:\\ 0\\.001799286498810632\ \(0\)\
